Despite the remarkable efficacy of COVID-19 vaccines, waning immunity, and the
emergence of SARS-CoV-2 variants such as Omicron represents a major global health …

Up to 25% of SARS-CoV-2 patients exhibit post-acute cognitive sequelae. Although millions
of cases of COVID-19-mediated memory dysfunction are accumulating worldwide, the …

ABSTRACT mRNA-1273 vaccine efficacy against SARS-CoV-2 Delta wanes over time;
however, there are limited data on the impact of durability of immune responses on …

Background Biologic therapies inhibiting the IL-4 or IL-5 pathways are very effective in the
treatment of asthma and other related conditions. However, the cytokines IL-4 and IL-5 also …

Waning immunity after two SARS-CoV-2 mRNA vaccinations and the emergence of variants
precipitated the need for a third dose of vaccine. We evaluated early safety and …

Objective A 6-month longitudinal surveillance study of asymptomatic healthcare providers
(HCP) was carried out at a large urban academic medical center in the United States to …

Already at the very beginning of the COVID-19 pandemic, an extensive PCR and antigen
testing strategy was considered necessary and subsequently also proved successful in …

Since their first documentation in 1952, plaque reduction neutralization tests (PRNTs) have
become the choice of test for the measurement of neutralizing antibodies against a particular …

The coronavirus disease 2019 pandemic (COVID-19) has highlighted the need for rapid
assays to accurately measure the infectivity of emerging SARS-CoV-2 variants and the …

Neutralizing antibody plays a key role in protective immunity against COVID-19. As
increasingly distinct variants circulate, debate continues regarding the value of adding novel …